Extended En Bloc Reoperation for Recurrent or Persistent Parathyroid Carcinoma: Analysis of 31 Cases in a Single Institute Experience

被引:19
作者
Wei, Bojun [1 ]
Zhao, Teng [1 ]
Shen, Hong [1 ]
Jin, Mulan [2 ]
Zhou, Quan [3 ]
Liu, Xing [1 ]
Wang, Jiacheng [1 ]
Wang, Qian [1 ]
机构
[1] Capital Med Univ, Dept Thyroid & Neck Surg, Beijing Chaoyang Hosp, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Chaoyang Hosp, Dept Pathol, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Dept Pathol, Beijing, Peoples R China
关键词
PROGNOSTIC-FACTORS; GUIDELINES; MANAGEMENT; DIAGNOSIS; CANCER; UPDATE;
D O I
10.1245/s10434-021-10962-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Parathyroid carcinoma (PC) is a rare malignancy that is difficult to eradicate completely after recurrence. We assessed the efficiency of extended en bloc resection (EEBR) in the management of recurrent or persistent PC. Methods In this observational cohort study, 31 patients who underwent reoperations for recurrent or persistent PC were enrolled after 2-9 surgeries by other medical teams. EEBRs, which provided the oncologic resection by removing all possible tumor-bearing scar tissues, were adopted in 25 patients. The other 6 with gross infiltration into the upper aerodigestive tract (UAT) underwent less radical procedures for unwillingness to sacrifice laryngeal function. Results The 5-year overall survival (OS) rate after EEBR was 59.6% compared with 16.7% after less radical procedures, with an improved median expected survival time of 90.0 months compared with 13.0 months after local excision. EEBR exhibited a favorable local control of relapses in 84.0% of patients after a median follow-up period of 27.0 months, 40.0% even achieved disease-free survival, although 56.0% had subsequent distant metastases (DMs) and suffered a worse 5-year OS of 36.7% in contrast with 100.0% in the absence of DM (p = 0.011). UAT invasion, rather than age, number of previous operations, or preoperative PTH levels, was the unique independent factor associated with both DM (HR = 5.466, p = 0.006) and mortality (HR = 7.606, p = 0.011). Conclusion EEBRs provide better outcomes than other conventional surgical approaches and might offer a second chance of cure for patients with recurrent or persistent PC in the absence of DM.
引用
收藏
页码:1208 / 1215
页数:8
相关论文
共 19 条
  • [1] Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center
    Asare, Elliot A.
    Silva-Figueroa, Angelica
    Hess, Kenneth R.
    Busaidy, Naifa
    Graham, Paul H.
    Grubbs, Elizabeth G.
    Lee, Jeffrey E.
    Williams, Michelle D.
    Perrier, Nancy D.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (11) : 3593 - 3599
  • [2] Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB)
    Asare, Elliot A.
    Sturgeon, Cord
    Winchester, David J.
    Liu, Lei
    Palis, Bryan
    Perrier, Nancy D.
    Evans, Douglas B.
    Winchester, David P.
    Wang, Tracy S.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (12) : 3990 - 3995
  • [3] Parathyroid Carcinoma: A 43-Year Outcome and Survival Analysis
    Harari, Avital
    Waring, Avantika
    Fernandez-Ranvier, Gustavo
    Hwang, Jimmy
    Suh, Insoo
    Mitmaker, Elliot
    Shen, Wen
    Gosnell, Jessica
    Duh, Quan-Yang
    Clark, Orlo
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (12) : 3679 - 3686
  • [4] Is central lymph node dissection necessary for parathyroid carcinoma?
    Hsu, Kun-Tai
    Sippel, Rebecca S.
    Chen, Herbert
    Schneider, David F.
    [J]. SURGERY, 2014, 156 (06) : 1336 - 1341
  • [5] THE INFLUENCE OF SURGICAL EXTENT AND PARAFIBROMIN STAINING ON THE OUTCOME OF PARATHYROID CARCINOMA: 20-YEAR EXPERIENCE FROM A SINGLE INSTITUTE
    Hu, Ya
    Bi, Yalan
    Cui, Ming
    Zhang, Xiang
    Su, Zhe
    Wang, Mengyi
    Hua, Surong
    Liao, Quan
    Zhao, Yupei
    [J]. ENDOCRINE PRACTICE, 2019, 25 (07) : 634 - 641
  • [6] Localization and reoperation results for persistent and recurrent parathyroid carcinoma
    Kebebew, E
    Arici, C
    Duh, JY
    Clark, OH
    [J]. ARCHIVES OF SURGERY, 2001, 136 (08) : 878 - 883
  • [7] Pradhan R., 2018, Evidence Based Endocrine Surgery, P307
  • [8] A nationwide study on parathyroid carcinoma
    Ryhanen, Eeva M.
    Leijon, Helena
    Metso, Saara
    Eloranta, Eija
    Korsoff, Pirkko
    Ahtiainen, Petteri
    Kekalainen, Paivi
    Tamminen, Marjo
    Ristamaki, Raija
    Knutar, Otto
    Loyttyniemi, Eliisa
    Niskanen, Leo
    Vaisanen, Mika
    Heiskanen, Ilkka
    Valimaki, Matti J.
    Laakso, Markku
    Haglund, Caj
    Arola, Johanna
    Schalin-Jantti, Camilla
    [J]. ACTA ONCOLOGICA, 2017, 56 (07) : 991 - 1003
  • [9] PROGNOSTIC FACTORS IN PARATHYROID CANCER - A REVIEW OF 95 CASES
    SANDELIN, K
    AUER, G
    BONDESON, L
    GRIMELIUS, L
    FARNEBO, LO
    [J]. WORLD JOURNAL OF SURGERY, 1992, 16 (04) : 724 - 731
  • [10] Diagnosis and management of parathyroid cancer
    Schulte, Klaus-Martin
    Talat, Nadia
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (10) : 612 - 622